MedVital key facts
as of Oct 2026- Developer of wound therapy products and technologies designed to advance wound care, wound closure, tissue regeneration, and scar management.
- MedVital is valued at approximately $4.5M as of Oct 2026 (last reported valuation).
- It has raised $1.1M; the latest was Seed Round ($1.1M) in May 2025.
- Notable investors include Group of Marquee Investors, 4point0 Health Ventures, Alkemi Growth Capital.
- Status: Privately Held (backing).
MedVital's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·Watch MedVital: the Monday email on marks, rounds and moves
MedVital funding rounds
No funding rounds for MedVital are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs MedVital
3MedVital valuation
MedVital's last reported valuation was $4.5 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
MedVital investors
3 investors are on record for MedVital, including Group of Marquee Investors, 4point0 Health Ventures and Alkemi Growth Capital.
About MedVital
Developer of wound therapy products and technologies designed to advance wound care, wound closure, tissue regeneration, and scar management. The company offers advanced Negative Pressure Wound Therapy (NPWT) systems with real-time leakage monitoring, portability and ease of use, enabling both patients and healthcare professionals to experience superior wound care.
- Sector
- Healthcare
- HQ
- Gurugram, India
- Founded
- 2024
- Employees
- 11
- Website
- themedvital.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.